CID 135210935

Luvometinib

Structural Information

Molecular Formula
C26H22F2IN5O4S
SMILES
CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(N=C2C4=CC(=CC=C4)NS(=O)(=O)C5CC5)C6CC6
InChI
InChI=1S/C26H22F2IN5O4S/c1-33-24-20(23(21(28)26(33)36)30-19-10-5-14(29)12-18(19)27)25(35)34(16-6-7-16)31-22(24)13-3-2-4-15(11-13)32-39(37,38)17-8-9-17/h2-5,10-12,16-17,30,32H,6-9H2,1H3
InChIKey
RJFDJJABNSVLRB-UHFFFAOYSA-N
Compound name
N-[3-[6-cyclopropyl-3-fluoro-4-(2-fluoro-4-iodoanilino)-1-methyl-2,5-dioxopyrido[2,3-d]pyridazin-8-yl]phenyl]cyclopropanesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

3
Patents

665.0405 Da
Monoisotopic Mass

4.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 666.04778 231.0
[M+Na]+ 688.02972 233.9
[M-H]- 664.03322 232.7
[M+NH4]+ 683.07432 220.8
[M+K]+ 704.00366 229.7
[M+H-H2O]+ 648.03776 218.3
[M+HCOO]- 710.03870 237.4
[M+CH3COO]- 724.05435 231.0
[M+Na-2H]- 686.01517 220.4
[M]+ 665.03995 233.6
[M]- 665.04105 233.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe